发明名称 |
BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF |
摘要 |
<p>Disclosed is a compound represented by the following formula: (wherein R<SUP>1</SUP> presents an optionally substituted hydrocarbon group, an optionally substituted amino group, an optionally substituted hydroxy group or an optionally substituted heterocyclic group; R<SUP>2</SUP> represents a hydrogen atom or an optionally substituted hydrocarbon group; Xa and Xb each represents C, N, O or S; Xc and Xd each represents C or N; m represents a number of 0-2; n represents a number of 1-3; ring A represents an optionally substituted 5-membered ring; ring B represents an optionally substituted 6-membered ring; and ring C represents an optionally substituted 3- to 5-membered ring; provided that when Xa, Xc and Xd are C, Xb is N or S) or a salt thereof, which is useful as an agent for prevention/treatment of diseases associated with action of melatonin.</p> |
申请公布号 |
WO2008136382(A1) |
申请公布日期 |
2008.11.13 |
申请号 |
WO2008JP58020 |
申请日期 |
2008.04.25 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED;KOIKE, TATSUKI;TAKAI, TAKAFUMI;HOASHI, YASUTAKA |
发明人 |
KOIKE, TATSUKI;TAKAI, TAKAFUMI;HOASHI, YASUTAKA |
分类号 |
C07D231/56;A61K31/416;A61K31/428;A61K31/433;A61K31/437;A61P1/04;A61P3/06;A61P3/10;A61P5/00;A61P7/10;A61P7/12;A61P9/00;A61P9/10;A61P9/12;A61P11/08;A61P15/00;A61P15/08;A61P19/10;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/02;A61P27/06;A61P35/00;A61P35/02;A61P37/00;A61P43/00;C07D275/04;C07D277/64;C07D285/14;C07D471/04;C12N15/00 |
主分类号 |
C07D231/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|